Events - Page 7

What were the most important biotechnology debates in 2010? What will be important in 2020?

This year's Darwin Day event covers a moonshot for biology: Resolving all genomes on earth within a decade! Speakers: Kerstin Lindblad-Toh, Josefin Stiller, Maren Wellenreuther, and Tom Gilbert.

LMI and partners welcome you to join this  day with presentations and discussions from the Norwegian life science ecosystem and industry leaders from Global Pharma.

For boys in upper secondary schools.

How are international regulations of pollutants followed up nationally and locally in Norway and Tanzania?

The workshop will bring together Norwegian and Tanzanian environmental authorities to address how international regulations on persistent organic pollutants are met nationally and locally.

What is happiness? What does it take to create and live a happy life? Is happiness more readily available to those who are able to see meaning in the little things? Is there any universal answer to what happiness really is to man?

NanoCosmos shows striking microscopy images from researchers in the convergence environment Programming Cell-Like Compartments. They will give you a glimpse into the nanoworld of soft matter and the microworld of cells ¨C a "Wunderkammer" ¨C where science becomes art. Join us for the opening February 11 at 18!

Climate change affects food production and food security. The way we produce food and what we eat affects the climate. Join us when we put self-storage, food safety, biodiversity and sustainable diet on the menu with experts from UiO and NMBU.

At this seminar PhD students, postdocs and Master?s students in life sciences at UiO and NMBU had the opportunity to create networks outside academia. Watch videos from the event.

In this seminar international experts and junior speakers from the UiO:Life Science convergence environment PerCaThe will discuss innovative methods for personalized and precision cancer therapy. Topics covered in the seminar include drug sensitivity screening, machine learning and combined mathematical, statistical and imaging methods for cancer modeling and simulation of drug treatment. 

Collaboration between Pharma industry and Academia. The aim of the conference is to show how real world evidence (RWE) is changing the landscape for drug development and clinical use and to present RWE Initiatives that put the Nordic region in the forefront.

Refreshments and mingling in Oslo City Hall  for all participants of the conference. You need at ticket to attend the reception. All who have registered, will get their ticket on email by the end of week 6. The reception is fully booked, but you may sign up for the waiting list.

At the Oslo Life Science Conference 5-year anniversary we looked ahead into the new decade. What will life sciences bring us in 2020¨C2030? What is the role of artificial intelligence (AI)? What are the visions for academia, hospitals and industry in a rapidly changing world where we need sustainable solutions? How can Oslo and Norway strengthen its position as a leading life science hub in Europe?

To develop your idea into a growing business you need an excellent and well-functioning team. Learn more about what it takes to build a team and establish and grow a successful business and use the opportunity to discuss with an experienced industry expert during this interactive seminar.

Dr. Colm Ryan, Assistant Professor at the University College Dublin, will present the lecture "Identifying robust genetic interactions in cancer."

Forming a business partnership can be beneficial or even vital to obtain success, but it has to be done correctly. If not, it can be catastrophic. Learn more about what it takes to secure a successful partnering and finance setup. What are the pitfalls? What is critical? What are the dos and don'ts?

Procedures that work in the lab don¡¯t always scale-up seamlessly into production in the life science industry. Process development while staying compliant will be required. What should be considered when you work in lab-scale to make the transition to production smoother? What are the common pitfalls, and what are the dos and don¡¯ts?

Dr. Tero Aittokallio, Professor at the Oslo Centre for Biostatistics and Epidemiology and Group Leader at the Institute for Cancer Research, Oslo, Norway, will present his lecture "Predictive modelling of drug combination effects for precision medicine."

Vi feirer 50-?rsdagen for Odd Hassels Nobelpris i kjemi: Program og p?melding til Hassel-seminaret 31. oktober til og med 1. november. 

This symposium brings together world leaders in the ER proteostasis field in Oslo to showcase new research in this burgeoning field and its links to different aspects of normal cellular function as well as disease states, and aims stimulate new collaborative research.

Repurposing of drugs can potentially bring medications with known safety profiles to new patient groups. What is the industry looking for when they consider to invest in a repurposing project? What is the regulatory framework in this area? How is IP handled?

We are pleased to announce that Dr. Adam Novak will be the guest speaker of our upcoming Sven Furberg Seminar in Bioinformatics and Statistical Genomics on the coming Friday, Sep 27, at 14:30 in Lille auditorium, Kristen Nygaards hus.

Dr. Adam Novak, senior software engineer in the UCSC Genomics Institute, will present his lecture "Graph-based genome representations".

Abstract:

Graph-based approaches to genomics problems can beat out traditional linear-reference-based tools, reducing reference allele bias and improving structural variant calling. For these reasons and others, graph genomics techniques are becoming more popular, and more graph-based tools are being developed. Here I present lessons on genome graph API design learned during the development of the vg variation graph toolkit. I show how techniques and libraries extracted from vg can be used to help developers quickly bootstrap new graph-based projects, forming an ecosystem of interoperable graph genomics tools.

A part of Nordic Life Science Awards that features exciting academic projects from five Nordic countries illustrating the rich and broad research milieus and their motivation to advance their ideas into innovations for patients.

Clinical trials are essential to develop new treatments. What are the fundamental issues that must be considered when designing clinical trials? What are the pitfalls? What are the dos and don¡¯ts?